UBS Group
MD icon

UBS Group’s Pediatrix Medical MD Stock Holding History

UBS Group’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-150,000
Closed -$6.49M – 8140
2018
Q2 		$6.49M Buy
150,000
+50,000
+50% +$2.4M ﹤0.01% 2116
2018
Q1 		$5.56M Buy
+100,000
New +$5.48M ﹤0.01% 2198

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

UBS Group's MD Position: Q2 2026 in Review

UBS Group increased its Pediatrix Medical (MD) stake by 47% in Q2 2026, buying an estimated $3.17M and bringing the position to 435,819 shares worth $11M. The position accounts for ﹤0.01% of the portfolio, ranked #3335.

UBS Group first reported a position in MD in Q4 2014 and has held it in 47 quarters since. The position peaked at $12.5M in Q4 2025. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • UBS Group held 435,819 shares of Pediatrix Medical worth $11M as of Q2 2026.
  • UBS Group bought 139,337 Pediatrix Medical shares in Q2 2026, an estimated $3.17M.
  • Pediatrix Medical made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3335 holding.
  • UBS Group first reported a position in Pediatrix Medical in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Pediatrix Medical position peaked at $12.5M in Q4 2025.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.